एपीए उद्धरण

Dong, K., Liang, W., Zhao, S., Guo, M., He, Q., Li, C., . . . Xia, X. (2019). EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases. Transl Lung Cancer Res.

शिकागो स्टाइल उद्धरण

Dong, Kai, Wenhua Liang, Shen Zhao, Minzhang Guo, Qihua He, Caichen Li, Haiqing Song, Jianxing He, और Xiaojun Xia. "EGFR-TKI Plus Brain Radiotherapy Versus EGFR-TKI Alone in the Management of EGFR-mutated NSCLC Patients With Brain Metastases." Transl Lung Cancer Res 2019.

एमएलए उद्धरण

Dong, Kai, et al. "EGFR-TKI Plus Brain Radiotherapy Versus EGFR-TKI Alone in the Management of EGFR-mutated NSCLC Patients With Brain Metastases." Transl Lung Cancer Res 2019.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.